BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions

Recombinant human albumin is a critical component in the manufacture of innovative biopharmaceuticals, particularly for modalities such as cell therapies...

August 09, 2022 | News

10x Genomics Reports Second Quarter 2022 Financial Results

Recent Highlights Revenue was $114.6 million for the second quarter, representing a 1% decrease over the corresponding period of 2021. Announ...

August 09, 2022 | News

Xinhua Silk Road: E. China's Wuxi city steps up biomedical industry development

Biomedical industry is an important part of Wuxi's modern industrial system construction during the 14th Five-Year Plan(2021-2025) period. Its scale topped...

August 09, 2022 | News

Biosynth Carbosynth to offer Enzyme Development following Acquisition of EUCODIS Bioscience

Biosynth Carbosynth (“Biosynth”), a supplier of critical materials to the life science industry, announces today that it has signed an agreemen...

August 08, 2022 | News

Thermo Fisher's $76 million investment expands cell culture media production

To meet increasing global demand for cell culture media used in the manufacturing of new vaccines and biologics, Thermo Fisher Scientific has expanded its ...

August 04, 2022 | News

Agilent Acquires Polymer Standards Service, Broadening Offerings for GPC/SEC Polymer Analysis

PSS specializes in hardware and software solutions used in defining the makeup and creation of molecular structures. The company provides complete solution...

August 03, 2022 | News

Sustainable Manufacturing Practices: The Key to Mitigating Antimicrobial Resistance

The workshop program included training on the importance of sustainability in manufacturing practices of antibiotics, as well as a presentation of th...

July 27, 2022 | News

CSafe Global Continues Investment in Cell and Gene Therapy Solutions with Addition of New Portfolio President

CSafe Global, the innovation leader in temperature-controlled shipping solutions for the transport of life-enhancing pharmaceuticals, announced today...

July 26, 2022 | News

Polpharma Biologics Announces FDA File Acceptance for Review of Natalizumab, First Proposed Biosimilar to Tysabri®

The application is for an intravenous (IV) route of administration, with the same dosing regimen, presentation and indication as the reference medicine, Ty...

July 26, 2022 | News

Liminal BioSciences Announces Discontinuation of Fezagepras Development

The decision to discontinue the development of fezagepras is based on results from the Phase 1a single ascending dose ("SAD") clinical trial, which indicat...

July 22, 2022 | News

Navigo Proteins Successfully Develops Affinity Resin Against Ferritin for Blood Fraction Processing

(“Navigo”), a premier protein engineering company and developer of affinity ligands for custom chromatography solutions, today announces succes...

July 21, 2022 | News

Brii Bio Announces Strategic Partnership with China Resources Pharmaceutical Commercial Group

The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China The ...

July 20, 2022 | News

Sobi to license loncastuximab tesirine from ADC Therapeutics

Sobi® announced an exclusive license agreement with ADC Therapeutics SA to develop and commercialise loncastuximab tesirine for use in haematology and ...

July 11, 2022 | News

WuXi XDC and AbTis Sign Memorandum of Understanding for Development and Manufacturing of Antibody Drug Conjugates

Under the partnership, AbTis will have access to WuXi XDC's integrated services for linker and payload manufacturing, ADC conjugation process developm...

July 08, 2022 | News

Stay Connected